Health in Central African Republic 1,256 indicators covering health for Central African Republic. IndicatorLatest Year10-yr change Rank Under 5 mortality rate - Current trends maintained 76.83 2030 down 12.1% 9th Under 5 mortality rate - High-income country average rate matched 5.09 2030 down 90.7% 1st Under 5 mortality rate - SDG target met 25 2030 down 65.3% 1st Mortality rate age 10-19 - Remains constant 20.27 2030 up 0.0% 7th Mortality rate age 10-19 - Current trends maintained 17.54 2030 down 11.3% 7th Mortality rate age 10-19 - High-income country average rate matched 5.66 2030 down 53.2% 2nd Neonatal deaths - Remains constant 8,181 2030 up 9.4% 44th Neonatal deaths - Current trends maintained 7,533 2030 up 2.1% 44th Neonatal deaths - SDG target met 3,280 2030 down 48.9% 54th Under-five deaths - Remains constant 23,849 2030 up 12.3% 40th Under-five deaths - Current trends maintained 20,423 2030 down 1.3% 40th Under-five deaths - SDG target met 6,692 2030 down 60.7% 53rd Deaths age 10 to 19 - Remains constant 3,326 2030 up 9.6% 52nd Deaths age 10 to 19 - Current trends maintained 2,891 2030 down 2.5% 53rd Mortality caused by road traffic injury 37.7 per 100,000 population 2019 up 17.8% 6th Mortality caused by road traffic injury, female 23.7 per 100,000 female population 2019 up 0.9% 4th Mortality caused by road traffic injury, male 52 per 100,000 male population 2019 up 27.8% 9th Ipv vaccine coverage 42 2024 up 2,000.0% 192nd Deaths in armed conflicts by country, annual growth rate -100 % change on previous year 2026 down 690.1% 33rd Deaths in armed conflicts by region, annual growth rate -100 % change on previous year 2026 down 690.1% 33rd Tb patients living with hiv receiving art 2,853 2021 up 4,095.6% 22nd HIV-positive TB patients on ART (antiretroviral therapy) 98.0% 2024 up 40.0% 64th Treatment success rate for patients treated for MDR-TB 69.0% 2021 down 14.8% 101st New leprosy case detection rate per 1 000 000 population 36.96 2024 up 155.9% 20th Treatment success rate: HIV-positive TB cases 90 2023 up 45.2% 22nd Prevalence of wasting, weight for height 5.2% 2022 down 29.7% 39th Estimated number of children (aged 0-17 years) who have lost one or 430,000 2024 up 4.9% 47th Weight-for-height <-2 SD 5.2 2022 down 29.9% 39th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 0.0% 2025 — 167th International Health Regulations core capacity scores, SPAR version 20 2025 — 162nd Prevalence of underweight, weight for age 18.4% 2022 down 24.9% 17th Leprosy registered prevalence rate per 1 000 000 population 36.96 2024 down 2.2% 21st Leprosy - Number of new leprosy cases among children 47 2024 up 235.7% 17th Leprosy - Number of cases registered for treatment 197 2024 up 10.7% 39th New leprosy child case detection rate (less than 15 years of age) per 17.99 2024 up 150.0% 12th Children (0-14) living with HIV 9,100 2024 down 39.3% 22nd Ipv1 number unvaccinated 117,638 2023 down 33.5% 33rd Children living with hiv 9,100 2024 down 39.3% 22nd Contraceptive prevalence, any method 17.8% 2019 up 17.3% 110th Children (ages 0-14) newly infected with HIV 1,000 2024 down 47.4% 22nd Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Number of children newly infected with hiv 1,000 2024 down 47.4% 22nd Share of children under fifteen years old with hiv 1,047 2024 down 46.2% 22nd Number of female leprosy new cases 89 2024 up 187.1% 30th Estimated number of malaria deaths 5,062 2024 down 13.3% 25th Estimated number of malaria cases 1.83 million 2024 down 5.7% 28th National smoking ban: NUMBER OF PLACES SMOKE-FREE 0 2022 — 157th Contraceptive prevalence, any modern method 14.4% 2019 up 27.1% 107th Number of prevalent tuberculosis cases 21,000 2014 down 38.2% 56th Estimated malaria incidence 343.84 2024 down 18.2% 4th Estimated malaria mortality rate 94.96 2024 down 24.8% 2nd Number of new G2D leprosy cases 31 2024 up 244.4% 31st Leprosy - New leprosy cases with G2D rate per 1 000 000 population 5.82 2024 up 191.7% 13th 3.7.2 Adolescent birth rate per 1,000 women 184 2018 down 19.6% 1st 3.1.2 Proportion of births attended by skilled health personnel 40 2019 down 8.5% 165th Inflation-adjusted prices for most sold brand of cigarettes: Prices 2.83 2022 up 70.5% 155th Taxes as a % of price: total tax 36.3% 2022 up 10.8% 141st Taxes as a % of price: value added tax 16.0% 2022 unchanged 42nd Taxes as a % of price: ad valorem excise 19.1% 2022 up 13.6% 63rd Taxes as a % of price: specific excise 1.2% 2022 — 133rd ← Previous Page 17 of 21 Next →